Tisbury Pharmaceutical Inc (Tisbury Pharmaceuticals BV). is a pharmaceutical company developing a first-in-class drug to treat glaucoma. Its primary development target is patients with open angle glaucoma and ocular hypertension patients.
Location: United States, Massachusetts, Beverly
Member count: 11-50
Total raised: $32M
Founded date: 2017
Investors 1
Date | Name | Website |
19.02.2021 | HealthCap | healthcap.... |
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
16.06.2017 | Series A | $32M | - | healthcap.... |
Mentions in press and media 2
Date | Title | Description | Category | Author | Source |
16.06.2017 | Tisbury Ph... | Tisbury Pharmaceuticals, Inc.,... | USA | - | finsmes.co... |
- | Tisbury Ph... | Boston, Massachusetts (PRWEB) ... | - | - | healthcap.... |